heart failure

Waqas SA, Ibrahim M, Ahmed M, Waqas M, Aamir J, Fudim M, Musani MH, Fonarow GC, Greene SJ. Cardiovascular outcomes of glucagon-like peptide-1 receptor agonists[...]

Sato N, Okami S, Yoshikawa-Ryan K, Yamashita S, Kobayashi R, Arita Y, Kim SW, Knapp R, Holl K, Fonarow GC. Pharmacological treatments and clinical events[...]

Shiraishi Y, Nakamaru R, Kohsaka S, Sandhu AT, Heidenreich PA, Ikemura N, Sawano M, Niimi N, Kimura T, Katsumata Y, Nishiyama T, Ueda I, Takatsuki[...]

Goel K, Lindman BR, Schwartz A, Cohen DJ, Giustino G, Oldemeyer JB, Strote J, Babaliaros V, Devireddy CM, Fischbein MP, Fearon WF, Daniels D, Spies[...]

Sandhu AT, Vasti E. 12 Is the New 23: Health Status Assessment in Heart Failure Trials. J Am Coll Cardiol. 2026 May 20:S0735-1097(26)06202-9. doi: 10.1016/j.jacc.2026.03.162.[...]

Brownell N, Solomon N, Greene SJ, Chiswell K, Vaduganathan M, Yancy C, Hsue P, Ziaeian B, Fonarow GC. Clinical Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Among[...]

Cai A, Liu L, Feng Y, Zhou Y, Li L, Bozkurt B, Januzzi JL, Lam CSP, Fonarow GC, Pandey A, Zhou Z, Cheng Y, Bayes-Genis[...]

Haywood HB, Ikeaba U, Fonarow GC, Xu H, Selvaraj S, Lewsey SC, Alhanti B, McDermott JJ, Wright J, Vaduganathan M, Greene SJ. Outpatient clinic visits[...]

Tanosaki S, Zhang Y, Bedi K, Margulies K, Cox JE, Arany Z, Abel ED. Choice of cardioplegia influences metabolomics of human cardiac tissue. Proc Natl[...]

Hamilton DE, Shriver JL, Patel SM, Park JG, Michos ZE, Mathis MR, Adie SK, Alviar CL, Barnett CF, Berg DD, Bennett CE, Bohula EA, Carnicelli[...]